Allograft rejection is a major problem in organ or cell transplantation. Development of a method for induction of specific tolerance to allografts, without the need for immunosuppression, would be a major advance in transplantation biology. Recently, adult rodent models of transplantation tolerance has been developed in several laboratories. Long-term tolerance to allogeneic hepatocytes has been induced in recipient genetically analbuminemic (NAR) rats, by intrathymic inoculation of donor splenocytes along with ablation of peripheral lymphocytes by injection of anti lymphocyte serum. Hepatocytes from the donor strain transplanted into NAR recipients 2-3 weeks later, were permanently accepted. Mechanisms by which tolerance is induced in these animals are unclear. The tolerance may be mediated by clonal deletion or clonal anergy of alloreactive T cells, or by the development of a negative regulatory mechanism. It is unknown whether persistence of donor type lymphocytes along with the recipient type cells (microchimerism) in the thymus or in the periphery is required to maintain tolerance, or secretion of soluble factors or recirculating cells from the graft are sufficient. This project aims to elucidate the mechanisms of allograft tolerance in a model system in which normal hepatocytes from allogeneic donors are transplanted into NAR recipients. Specifically, we will evaluate the possible role of donor microchimerism in the induction or maintenance of tolerance, identify of the type of cells that are involved in tolerance induction, determine whether tolerance can be induced or maintained by soluble MHC class l, and assess the possible role of regulatory T cells in tolerance induction or maintenance. Successful elucidation of the mechanisms of allograft tolerance should provide key information towards the translation of animal models to the realm of human transplantation.

Project Start
1998-06-24
Project End
1999-05-31
Budget Start
Budget End
Support Year
10
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Akiyama, Matthew J; Agyemang, Linda; Arnsten, Julia H et al. (2018) Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy. BMC Infect Dis 18:74
Willis, Ian M (2018) Maf1 phenotypes and cell physiology. Biochim Biophys Acta Gene Regul Mech 1861:330-337
Wang, Tony Y; Portincasa, Piero; Liu, Min et al. (2018) Mouse models of gallstone disease. Curr Opin Gastroenterol 34:59-70
Hodge, Dayle Q; Cui, Jihong; Gamble, Matthew J et al. (2018) Histone Variant MacroH2A1 Plays an Isoform-Specific Role in Suppressing Epithelial-Mesenchymal Transition. Sci Rep 8:841
Sharma, Yogeshwar; Liu, Jinghua; Kristian, Kathleen E et al. (2018) In Atp7b-/- Mice Modeling Wilson's Disease Liver Repopulation with Bone Marrowderived Myofibroblasts or Inflammatory Cells and not Hepatocytes is Deleterious. Gene Expr :
Stepankova, Martina; Bartonkova, Iveta; Jiskrova, Eva et al. (2018) Methylindoles and Methoxyindoles are Agonists and Antagonists of Human Aryl Hydrocarbon Receptor. Mol Pharmacol 93:631-644
Walters, Ryan O; Arias, Esperanza; Diaz, Antonio et al. (2018) Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans. Cell Rep 25:663-676.e6
Liu, Zhongbo; Apontes, Pasha; Fomenko, Ekaterina V et al. (2018) Mangiferin Accelerates Glycolysis and Enhances Mitochondrial Bioenergetics. Int J Mol Sci 19:
Tekirdag, Kumsal; Cuervo, Ana Maria (2018) Chaperone-mediated autophagy and endosomal microautophagy: Joint by a chaperone. J Biol Chem 293:5414-5424
Zhao, Rongbao; Najmi, Mitra; Aluri, Srinivas et al. (2018) Concentrative Transport of Antifolates Mediated by the Proton-Coupled Folate Transporter (SLC46A1); Augmentation by a HEPES Buffer. Mol Pharmacol 93:208-215

Showing the most recent 10 out of 451 publications